Johnson & Johnson in talks to acquire Intra-Cellular – Bloomberg
yuelan Johnson & Johnson (JNJ) is in discussions to purchase Intra-Cellular Therapies (NASDAQ:ITCI). A deal may happen as soon as this week, according to a Bloomberg report on Sunday, which cited people familiar with the matter.Talks are ongoing and a deal